Alto Neuroscience (ANRO) Assets Average (2024 - 2026)

Alto Neuroscience (ANRO) has 3 years of Assets Average data on file, last reported at $230.5 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 31.9% year-over-year to $230.5 million; the trailing twelve-month figure through Mar 2026 stood at $230.5 million (up 31.9% YoY), and the FY2025 full-year result was $181.1 million, up 37.12% from the prior year.
• Assets Average grew to $230.5 million in Q1 2026, from $165.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $230.5 million in Q1 2026 to a low of $148.3 million in Q1 2024.
• A 3-year average of $179.9 million and a median of $174.7 million in 2025 frame the typical range for Assets Average.
• Across the five-year window, Assets Average dropped 21.62% in 2025 and jumped 31.9% in 2026, its largest moves.
• Tracing ANRO's Assets Average over 3 years: stood at $184.6 million in 2024, then declined by 10.15% to $165.8 million in 2025, then soared by 38.97% to $230.5 million in 2026.
• Business Quant data shows ANRO's Assets Average at $230.5 million in Q1 2026, $165.8 million in Q4 2025, and $152.4 million in Q3 2025.